FDAQRC Acquires Compliance Architects to Enhance Global Regulatory Expertise
FDAQRC has acquired Compliance Architects LLC, expanding its expertise in global regulatory compliance for pharmaceutical and medical device companies. The deal strengthens FDAQRC's position in the sector.
FDAQRC acquired Compliance Architects LLC on July 17, 2026, deepening its role as a global regulatory compliance expert for pharmaceutical and medical device companies.
The acquisition combines two established consulting firms, offering services to companies navigating complex international regulations. Compliance Architects brings extensive experience in meeting requirements from the U.S. Food and Drug Administration (FDA) and other international regulatory bodies.
FDAQRC has previously focused on assisting companies with global market access regulations for medical devices and pharmaceuticals. The expertise from Compliance Architects broadens FDAQRC's offerings to include a more comprehensive approach to the U.S. market and its specific demands.
The corporate deal is expected to enhance FDAQRC's capacity to provide comprehensive solutions to its clients, aiming to streamline the development and global market introduction of medical and pharmaceutical products.